Exavir is a New York-based biotechnology company that develops and commercializes therapeutics for the treatment of HIV and infectious diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Address: -
City: New York
State: NY
Zip: -
Country: US
Exavir is a New York-based biotechnology company that develops and commercializes therapeutics for the treatment of HIV and infectious diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Seed | 2 | $4M |
Gilead Sciences AlleyCorp AlleyCorp Gilead Sciences |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|